Connect with us

Hi, what are you looking for?

Thursday, Feb 22, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Avextra imports medical cannabis extracts to Italy

Italy has the second largest patient population for medical cannabis in the European Union

Avextra imports medical cannabis extract to Italy
Image via Avextra

Germany’s Avextra AG, a medical cannabis company partly owned by Seed Innovations Ltd (LON: SEED), has expanded its European footprint by shipping EU-GMP certified cannabis extracts to Italy.

Avextra announced the accomplishment on Wednesday and says it is one of only three companies permitted to import medical cannabis products into the country.

The company also says that Italy has the second largest patient population for medical cannabis products in the European Union and that 70 per cent of that market is allocated to extracts like the ones Avextra has now imported.

“We have had extensive discussions with Italian doctors and pharmacies and see a clear need for standardized extracts in Italy,” said Avextra’s Co-CEO Bernhard Babel.

“Our Italian team have regularly participated in scientific conferences and built relationships with leading researchers and clinicians and see strong potential for medical cannabis therapies to grow and develop in Italy.”

Read more: Clever Leaves gets Brazilian GMP cannabis certification

Read more: Switzerland approves more adult-use cannabis pilot projects

Avextra announced on Monday that it had raised £17 million to help expand its business from a series of private investors.

In February, the company began exporting its extracts into the United Kingdom where it currently holds an ownership stake in a series of medical cannabis dispensaries owned by Integro Medical Clinics.

Avextra owns a substantial cannabis cultivation facility in Portugal in addition to the German facility where the extracts were produced. The company was formerly known as the Eurox Group before rebranding itself as Avextra last fall.

Seed says that as of September 30 last year it owned a 6.6 per cent stake in Avextra on a fully diluted basis valued at approximately £4.4 million.

Seed’s shares are currently worth the equivalent of $0.03 on the London Stock Exchange, dropping by 0.79 per cent Wednesday.


Follow Mugglehead on Twitter

Follow Rowan Dunne on Twitter




Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AI and Autonomy

The act uses a risk-based approach, prioritizing high-risk areas such as government use of AI for biometric surveillance


German officials who met with the Argentinian delegation will be travelling to South America next month to further strengthen ties


European demand continued to plummet with a year-on-year decrease of 59 per cent


The country would become the first in Europe to legalize